Johnson & Johnson runs into vaccine supply issues in Europe, threatening second-quarter delivery pledge: Reuters
Mar 9, 2021 10:30am Johnson & Johnson is one of several companies working around the clock to scale up vaccine supply. (Kunal Mahto/iStock/Getty Images Plus/Getty Images) Johnson & Johnson execs have assured investors and officials that the company is "comfortable" hitting its vaccine delivery targets. But with its U.S. rollout underway, the pharma giant has run into some supply problems in Europe, Reuters reports. J&J’s shot isn’t yet authorized in Europe, but the company has been gearing up to supply a promised 55 million doses during the second quarter—and now it's hitting some...